{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:38Z","timestamp":1786993718180,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.leukres.2024.107610","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:27:27Z","timestamp":1730093247000},"page":"107610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Epidemiological and genetic insights into the co-occurrence of cutaneous melanoma and hematologic malignancies: A meta-analytic review"],"prefix":"10.1016","volume":"147","author":[{"given":"Ashmitha","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunan","family":"Jeyakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2024.107610_bib1","doi-asserted-by":"crossref","unstructured":"Travis L.B. The epidemiology of second primary cancers. American Association for Cancer Research. November 21, 2006. Accessed July 16, 2023. https:\/\/aacrjournals.org\/cebp\/article\/15\/11\/2020\/275025\/The-Epidemiology-of-Second-.","DOI":"10.1158\/1055-9965.EPI-06-0414"},{"issue":"9","key":"10.1016\/j.leukres.2024.107610_bib2","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jdv.13645","article-title":"Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy","volume":"30","author":"Caini","year":"2016","journal-title":"J. Eur. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.leukres.2024.107610_bib3","first-page":"207","article-title":"Multiple cancer--an epidemiologic exercise in Finland","volume":"75","author":"Teppo","year":"1985","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.leukres.2024.107610_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/archsurg.1995.01430100034007","article-title":"LP. The association between melanoma, lymphoma, and other primary neoplasms","volume":"130","author":"Ariyan","year":"1995","journal-title":"Arch. Surg."},{"issue":"1","key":"10.1016\/j.leukres.2024.107610_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2133.2000.03610.x","article-title":"Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology?","volume":"143","author":"McKenna","year":"2000","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107610_bib6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jid.2018.11.001","article-title":"Risk of second primary cancer in survivors of in situ melanoma","volume":"139","author":"Kimlin","year":"2019","journal-title":"J. Invest Dermatol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107610_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Bradford","year":"2010","journal-title":"Arch. Dermatol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107610_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjc.6602654","article-title":"Second primary cancers among 109,000 cases of non-Hodgkin's lymphoma.","volume":"93","author":"Brennan","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2024.107610_bib9","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/bjc.1996.642","article-title":"Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers","volume":"74","author":"Levi","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2024.107610_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/jcp.2010.077768","article-title":"Lymphoma occurring in patients with cutaneous melanoma","volume":"63","author":"Verwer","year":"2010","journal-title":"J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.leukres.2024.107610_bib11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/djy052","article-title":"Mutual risks of cutaneous melanoma and specific lymphoid neoplasms: second cancer occurrence and survival","volume":"110","author":"Herr","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.leukres.2024.107610_bib12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/1097-0142(20010215)91:4<874::AID-CNCR1076>3.0.CO;2-O","article-title":"Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma","volume":"91","author":"Goggins","year":"2001","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2024.107610_bib13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/aje\/kwq262","article-title":"Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study","volume":"172","author":"Rebora","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.leukres.2024.107610_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41408-019-0237-1","article-title":"Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia","volume":"9","author":"Kumar","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2024.107610_bib15","first-page":"191","article-title":"Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82","volume":"68","author":"Greene","year":"1985","journal-title":"Natl. Cancer Inst. Monogr."},{"issue":"7","key":"10.1016\/j.leukres.2024.107610_bib16","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19910401)67:7<2002::AID-CNCR2820670729>3.0.CO;2-E","article-title":"Second cancers following non-Hodgkin's lymphoma","volume":"67","author":"Travis","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2024.107610_bib17","doi-asserted-by":"crossref","unstructured":"Page M.J., et al. The PRISMA 2020 statement: an updated guide-line for reporting systematic reviews. BMJ. 2021;372:n71\u2013n71.","DOI":"10.1136\/bmj.n71"},{"key":"10.1016\/j.leukres.2024.107610_bib18","unstructured":"Corp, I. IBM SPSS Statistics for Windows. Released. Armonk.NY: IBM Corp; 2021."},{"issue":"1","key":"10.1016\/j.leukres.2024.107610_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.bjc.6600692","article-title":"Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland","volume":"88","author":"McKenna","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.leukres.2024.107610_bib20","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/1097-0142(20010215)91:4<874::AID-CNCR1076>3.0.CO;2-O","article-title":"Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma","volume":"91","author":"Goggins","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2024.107610_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.leukres.2018.07.003","article-title":"Management of melanoma in patients with chronic lymphocytic leukemia","volume":"71","author":"Archibald","year":"2018","journal-title":"Leuk. Res"},{"issue":"3","key":"10.1016\/j.leukres.2024.107610_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdi080","article-title":"An association between cutaneous melanoma and non- Hodgkin's lymphoma: pooled analysis of published data with a review","volume":"16","author":"Lens","year":"2005","journal-title":"Ann. Oncol."},{"issue":"6993","key":"10.1016\/j.leukres.2024.107610_bib23","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/bmj.310.6993.1491","article-title":"Evidence of an association between non- Hodgkin's lymphoma and skin cancer","volume":"310","author":"Adami","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.leukres.2024.107610_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00008469-200402000-00006","article-title":"Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients","volume":"13","author":"Crocetti","year":"2004","journal-title":"Eur. J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.leukres.2024.107610_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaad.2009.07.039","article-title":"Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study","volume":"62","author":"Spanogle","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.leukres.2024.107610_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4143\/crt.2017.110","article-title":"Risk of second primary cancer in people with non- melanoma skin cancer: A Nationwide Cohort Study","volume":"50","author":"Wang","year":"2018","journal-title":"Cancer Res Treat."},{"issue":"2","key":"10.1016\/j.leukres.2024.107610_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.157.2.781","article-title":"Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms","volume":"157","author":"Donawho","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2024.107610_bib28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-023-06156-8","article-title":"Ultraviolet radiation shapes dendritic cell leukaemia transformation in the skin","volume":"618","author":"Griffin","year":"2023","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.leukres.2024.107610_bib29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjc.1996.169","article-title":"Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?","volume":"73","author":"McMichael","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"7039","key":"10.1016\/j.leukres.2024.107610_bib30","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/bmj.312.7039.1128","article-title":"Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales","volume":"312","author":"Bentham","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.leukres.2024.107610_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738915","article-title":"Secondary Immunodeficiency in Haematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia","volume":"12","author":"Allegra","year":"2021","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107610_bib32","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/ijms21051825","article-title":"Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions","volume":"21","author":"Arruga","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.leukres.2024.107610_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02121439","article-title":"Enhanced sensitivity of DEAE-dextran treated spleen cells from normal BALB\/C mice, B-lymphocyte depleted BALB\/C mice and nude mice to in vitro antibody-complement mediated immune cytolysis","volume":"160","author":"Ebbesen","year":"1974","journal-title":"Med Microbiol Immunol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107610_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1524-4725.2009.01447.x","article-title":"Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma","volume":"36","author":"Brewer","year":"2010","journal-title":"Dermatol. Surg."},{"issue":"28","key":"10.1016\/j.leukres.2024.107610_bib35","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1200\/JCO.2014.60.2094","article-title":"Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma","volume":"33","author":"Lam","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107610_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaoncol.2018.5625","article-title":"Association of Chemotherapy for Solid Tumors with Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era","volume":"5","author":"Morton","year":"2019","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107610_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/jnci\/88.5.270","article-title":"Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer","volume":"88","author":"Hawkins","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.leukres.2024.107610_bib38","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdf289","article-title":"Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time","volume":"13","author":"Foss Abrahamsen","year":"2002","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107610_bib39","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bcp.2010.04.029","article-title":"Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail","volume":"80","author":"Inamdar","year":"2010","journal-title":"Biochem Pharm."},{"issue":"2","key":"10.1016\/j.leukres.2024.107610_bib40","first-page":"253","article-title":"BRAF mutation in hairy cell leukemia","volume":"8","author":"Ahmadzadeh","year":"2014","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.leukres.2024.107610_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1479-5876-10-85","article-title":"The role of BRAF V600 mutation in melanoma","volume":"10","author":"Ascierto","year":"2012","journal-title":"J. Transl. Med"},{"issue":"24","key":"10.1016\/j.leukres.2024.107610_bib42","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.leukres.2024.107610_bib43","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/jid.2012.401","article-title":"Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions","volume":"133","author":"Jenkins","year":"2013","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107610_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<13::AID-IJC3>3.0.CO;2-#","article-title":"Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study","volume":"78","author":"Platz","year":"1998","journal-title":"Int J. Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2024.107610_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000372-199806000-00006","article-title":"p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry","volume":"20","author":"Sparrow","year":"1998","journal-title":"Am. J. Derm."},{"issue":"1","key":"10.1016\/j.leukres.2024.107610_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9440(10)63110-0","article-title":"Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study","volume":"164","author":"Alonso","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107610_bib47","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.V86.4.1548.bloodjournal8641548","article-title":"Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies","volume":"86","author":"Ogawa","year":"1995","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2024.107610_bib48","first-page":"3483","article-title":"Point mutations in the N-ras proto-oncogene in melanoma","volume":"8","author":"Crook","year":"1993","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.leukres.2024.107610_bib49","first-page":"625","article-title":"N-ras oncogene mutations in human acute myeloid leukemia: a study of bone marrow from 33 patients using oligodeoxyribonucleotide probes","volume":"64","author":"Catovsky","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107610_bib50","doi-asserted-by":"crossref","unstructured":"Qian S., Wei Z., Yang W., Huang J., Yang Y., Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022 Oct 12;12:985363. doi: 10.3389\/fonc.2022.985363. PMID: 36313628; PMCID: PMC9597512.","DOI":"10.3389\/fonc.2022.985363"},{"key":"10.1016\/j.leukres.2024.107610_bib51","doi-asserted-by":"crossref","unstructured":"Majid A., Tsoulakis O., Walewska R., Gesk S., Siebert R., Kennedy D.B., Dyer M.J. BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism. Blood. 2008 Jan 15;111(2):874-7. doi: 10.1182\/blood-2007-07-098681. Epub 2007 Oct 24. PMID: 17959858.","DOI":"10.1182\/blood-2007-07-098681"},{"issue":"3","key":"10.1016\/j.leukres.2024.107610_bib52","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_432650","article-title":"TP53 mutations in acute leukemias and myelodysplastic syndromes: Insights and treatment updates","volume":"44","author":"Santini","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.leukres.2024.107610_bib53","doi-asserted-by":"crossref","unstructured":"Molica M., Mazzone C., Niscola P., de Fabritiis P. TP53 mutations in acute myeloid leukemia: still a daunting challenge? Front Oncol. 2021;10:610820. doi: 10.3389\/fonc.2020.610820. PMID: 33628731; PMCID: PMC7897660.","DOI":"10.3389\/fonc.2020.610820"},{"issue":"17","key":"10.1016\/j.leukres.2024.107610_bib54","first-page":"5480","article-title":"Amplification of the N-myc gene in embryonal neuroblastoma","volume":"80","author":"Schwab","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.leukres.2024.107610_bib55","first-page":"6444","article-title":"Chromosomal translocation in Burkitt lymphoma and myeloma cells results from the fusion of immunoglobulin heavy-chain genes with the c-myc oncogene","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.leukres.2024.107610_bib56","first-page":"7313","article-title":"Loss of heterozygosity for the neurofibromatosis 1 gene in sporadic melanoma","volume":"87","author":"Xu","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"26","key":"10.1016\/j.leukres.2024.107610_bib57","first-page":"6784","article-title":"NF1 mutations in childhood acute myeloid leukemia","volume":"117","author":"Borgmann","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107610_bib58","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/s12885-021-08427-x","article-title":"Recurrent KRAS, KIT, and SF3B1 mutations in melanoma of the female genital tract","volume":"21","author":"Cai","year":"2021","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.leukres.2024.107610_bib59","first-page":"2249","article-title":"SF3B1 mutations in chronic lymphocytic leukemia: clinical and prognostic implications","volume":"123","author":"Papaemmanuil","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2024.107610_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.8.2.18","article-title":"Next-generation sequencing of uveal melanoma for detection of genetic alterations predicting metastasis","volume":"8","author":"Afshar","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"20","key":"10.1016\/j.leukres.2024.107610_bib61","first-page":"4143","article-title":"Mutations in U2AF1 in myelodysplastic syndromes with a normal karyotype","volume":"121","author":"Landau","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2024.107610_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.advms.2019.07.002","article-title":"a new diagnostic and prognostic marker in acute myeloid leukemia patients","volume":"64","author":"Mechaal","year":"2019","journal-title":"Adv. Med Sci."},{"issue":"6","key":"10.1016\/j.leukres.2024.107610_bib63","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/15384047.2016.1167291","article-title":"Role of EZH2 histone methyltransferase in melanoma progression and metastasis","volume":"17","author":"Mahmoud","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"9","key":"10.1016\/j.leukres.2024.107610_bib64","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3390\/cancers15092607","article-title":"BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge","volume":"15","author":"Florent","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.leukres.2024.107610_bib65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/bjh.13346","article-title":"Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era","volume":"169","author":"Gunnarsson","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107610_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00008390-199410000-00008","article-title":"Protein kinases in normal and transformed melanocytes","volume":"4","author":"Quong","year":"1994","journal-title":"Melanoma Res"},{"issue":"6","key":"10.1016\/j.leukres.2024.107610_bib67","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0749.1994.tb00072.x","article-title":"Evolutionary origin and molecular biology of the melanoma-inducing oncogene of Xiphophorus","volume":"7","author":"Schartl","year":"1994","journal-title":"Pigment Cell Res"},{"issue":"1","key":"10.1016\/j.leukres.2024.107610_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat. Genet"},{"key":"10.1016\/j.leukres.2024.107610_bib69","doi-asserted-by":"crossref","unstructured":"Makaranka S., Scutt F., Frixou M., Wensley K.E., Sharma R., Greenhowe J.. The gut microbiome and melanoma: A review. Exp Dermatol. 2022 Sep;31(9):1292-1301. doi: 10.1111\/exd.14639. Epub 2022 Jul 11. PMID: 35793428.","DOI":"10.1111\/exd.14639"},{"issue":"9","key":"10.1016\/j.leukres.2024.107610_bib70","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3324\/haematol.2021.280455","article-title":"The gut microbiome in patients with chronic lymphocytic leukemia","volume":"107","author":"Faitov\u00e1","year":"2022","journal-title":"Haematologica"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T09:16:32Z","timestamp":1732180592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624001760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":70,"alternative-id":["S0145212624001760"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107610","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological and genetic insights into the co-occurrence of cutaneous melanoma and hematologic malignancies: A meta-analytic review","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107610"}}